rel=”dofollow” href=”https://economictimes.indiatimes.com/pb-fintech-ltd/stocks/companyid-2017710.cms” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank”>PB Fintech, the parent company of insurance marketplace ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” target=”_blank” href=”https://economictimes.indiatimes.com/tech/policybazaar”>Policybazaar and credit marketplace ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/paisabazaar” target=”_blank”>Paisabazaar, has invested Rs 539.4 crore into its health subsidiary, ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/pb-healthcare-services” target=”_blank”>PB Healthcare Services. This marks the first tranche of a larger Rs 1,461.6 crore ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/seed-funding-round” target=”_blank”>seed funding round, which also includes participation from external investors.
The initial investment, approved by shareholders via postal ballot, was made through the subscription of 5.39 crore ref=”dofollow” data-ga-onclick=”Inarticle articleshow link click#Tech#href” href=”https://economictimes.indiatimes.com/topic/compulsory-convertible-preference” target=”_blank”>Compulsory Convertible Preference Shares (CCPS) at Rs 100 per share, as disclosed in a stock exchange filing.
The…
